Literature DB >> 15596299

Inhibition of osteopontin expression and function in oral cancer cell lines by antisense oligonucleotides.

Takashi Muramatsu1, Kaori Shima, Kazumasa Ohta, Harutoshi Kizaki, Yasufumi Ro, Yohko Kohno, Yoshihiro Abiko, Masaki Shimono.   

Abstract

We examined expression and function of osteopontin (OPN) in oral cancer cell lines using antisense oligonucleotide (AS). Quantitative real-time RT-PCR showed that expression in BSC-OF cells was significantly higher (10-fold) than that in KB cell. AS-study showed that foci of AS-treated BSC-OF cells possessed thin processes and radiated morphologically, although BSC-OF cells showed round foci. Cell growth in AS-group was lower (<80%) than the control. Invasion ability in AS-group became significantly lower (P<0.01). These results suggest that BSC-OF cell is useful for over-expression of OPN, and that OPN contributes to morphology, growth and invasion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596299     DOI: 10.1016/j.canlet.2004.05.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

Review 1.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

2.  Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.

Authors:  Wang Likui; Wang Hong; Zhang Shuwen
Journal:  J Gastrointest Surg       Date:  2009-09-18       Impact factor: 3.452

3.  Inhibition of osteopontin dependent carcinogenesis.

Authors:  Shailendra Kapoor
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-20       Impact factor: 4.553

4.  Evaluating the efficacy of osteopontin expression as a prognostic marker in oral squamous cell carcinoma in the Indian subpopulation.

Authors:  Yashwant Ingale; Samapika Routray; Supriya M Kheur; Mohit Kheur; Neeta Mohanty
Journal:  J Oral Maxillofac Pathol       Date:  2014-09

5.  Immunolocalization of osteopontin in dysplasias and squamous cell carcinomas arising from oral epithelium.

Authors:  Thara Aravind; Mahija Janardhanan; S Rakesh; Vindhya Savithri; U G Unnikrishnan
Journal:  J Oral Maxillofac Pathol       Date:  2017 Jan-Apr

6.  Osteopontin and oral carcinogenesis.

Authors:  Shailendra Kapoor
Journal:  J Cell Mol Med       Date:  2008-04-15       Impact factor: 5.310

Review 7.  Osteopontin at the Crossroads of Inflammation and Tumor Progression.

Authors:  Luigi Mario Castello; Davide Raineri; Livia Salmi; Nausicaa Clemente; Rosanna Vaschetto; Marco Quaglia; Massimiliano Garzaro; Sergio Gentilli; Paolo Navalesi; Vincenzo Cantaluppi; Umberto Dianzani; Anna Aspesi; Annalisa Chiocchetti
Journal:  Mediators Inflamm       Date:  2017-07-09       Impact factor: 4.711

8.  Parameters of Oxidative Stress, Vitamin D, Osteopontin, and Melatonin in Patients with Lip, Oral Cavity, and Pharyngeal Cancer.

Authors:  Jarosław Nuszkiewicz; Jolanta Czuczejko; Marta Maruszak; Marta Pawłowska; Alina Woźniak; Bogdan Małkowski; Karolina Szewczyk-Golec
Journal:  Oxid Med Cell Longev       Date:  2021-10-20       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.